| |
| |
|
| Insider
Information: |
Bradbury Daniel |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
232,105 |
|
|
Indirect Shares
|
3,161,475 |
|
|
| Direct
Value |
$2,471,016 |
|
|
|
Indirect Value
|
$4,283,565 |
|
|
| Total
Shares |
3,393,580 |
|
|
| Total
Value |
$6,754,581 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
President & Chief Exec... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2006-05-09 |
35,714 |
|
0 |
Premium* |
|
|
Illumina Inc |
ILMN |
Director |
2017-05-25 |
15,324 |
2008-05-16 |
0 |
Premium* |
|
|
Corcept Therapeutics Inc |
CORT |
Director |
2012-11-21 |
0 |
2019-02-07 |
130,575 |
Premium* |
|
|
Geron Corporation |
GERN |
Director |
2014-05-09 |
142,776 |
2019-03-29 |
51,323 |
Premium* |
|
|
Equillium Inc |
EQ |
Chief Executive Office... |
2018-10-16 |
0 |
2018-10-16 |
2,969,596 |
Premium* |
|
|
Castle Biosciences Inc |
CSTL |
Director |
2024-05-25 |
13,291 |
2024-05-06 |
9,981 |
Premium* |
|
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
25,000 |
2021-02-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
424 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 15 of 17
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ILMN |
Illumina Inc |
Director |
• • – |
2015-05-29 |
4 |
AS |
$206.30 |
$351,254 |
D/D |
(1,700) |
14,376 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
• • – |
2015-08-17 |
4 |
AS |
$208.11 |
$353,844 |
D/D |
(1,700) |
14,376 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-09-15 |
4 |
AS |
$168.43 |
$353,991 |
D/D |
(2,100) |
12,466 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-06-12 |
4 |
AS |
$170.55 |
$359,459 |
D/D |
(2,100) |
12,466 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-06-27 |
4 |
AS |
$171.12 |
$360,455 |
D/D |
(2,100) |
12,466 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-08-22 |
4 |
AS |
$171.95 |
$361,708 |
D/D |
(2,100) |
12,466 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2021-07-09 |
4 |
AS |
$70.37 |
$362,691 |
I/I |
(5,000) |
155,304 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-07-08 |
4 |
AS |
$171.32 |
$363,077 |
D/D |
(2,100) |
12,466 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2011-05-18 |
4 |
AS |
$73.02 |
$366,053 |
D/D |
(5,000) |
5,240 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-03-06 |
4 |
AS |
$171.86 |
$367,707 |
D/D |
(2,100) |
9,924 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2021-09-21 |
4 |
AS |
$73.82 |
$369,726 |
I/I |
(5,000) |
144,054 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-01-04 |
4 |
AS |
$20.40 |
$371,749 |
I/I |
(18,223) |
43,591 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
• • – |
2015-07-06 |
4 |
AS |
$218.67 |
$373,488 |
D/D |
(1,700) |
14,376 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2021-09-22 |
4 |
AS |
$73.90 |
$373,495 |
I/I |
(5,000) |
142,804 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-07-23 |
4 |
AS |
$176.37 |
$373,523 |
D/D |
(2,100) |
12,466 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
• • – |
2015-06-24 |
4 |
AS |
$220.61 |
$376,098 |
D/D |
(1,700) |
14,376 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-09-03 |
4 |
AS |
$178.21 |
$377,507 |
D/D |
(2,100) |
12,466 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2021-09-08 |
4 |
AS |
$75.88 |
$382,332 |
I/I |
(5,000) |
146,554 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-05-04 |
4 |
AS |
$21.29 |
$382,668 |
I/I |
(17,643) |
79,276 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2021-09-09 |
4 |
AS |
$76.14 |
$383,166 |
I/I |
(5,000) |
145,304 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-11-13 |
4 |
AS |
$184.56 |
$392,454 |
D/D |
(2,100) |
12,466 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-03-30 |
4 |
AS |
$44.04 |
$397,680 |
I/I |
(8,852) |
97,562 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-12-11 |
4 |
AS |
$58.77 |
$398,711 |
I/I |
(6,637) |
761,191 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-03-29 |
4 |
AS |
$44.81 |
$401,129 |
I/I |
(8,852) |
100,062 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-12-09 |
4 |
AS |
$62.73 |
$401,514 |
D/D |
(6,400) |
1,800 |
0 |
- |
|
424 Records found
|
|
Page 15 of 17 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
